跳至主要内容
临床试验/NL-OMON44602
NL-OMON44602已完成不适用

A randomized controlled trial to evaluate the efficacy of the Spinal Modulation Axium neurostimulator therapy as a treatment for persistent inguinal pain following surgical intervention. - SMASHING

Maxima Medisch Centrum0 个研究点目标入组 78 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
78

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Subject is at least 18 years old.
  • Subject is able and willing to comply with the follow-up schedule and protocol.
  • Chronic inguinal pain following pfannenstiel incision or inguinal hernia repair or laparoscopic inguinal repair for at least 6 months.
  • Previously undergone neurectomy procedure as a treatment for chronic inguinal pain.
  • Minimum baseline pain rating of 6 out of 10 in the inguinal area on an 11-point NPRS.
  • Subject is able to provide written informed consent.
  • Meets the inclusion criteria for the implantation of a neurostimulation system as set out by the Dutch Neuromodulation Society.
  • Subject has been screened by a multi-disciplanary panel including the designated psychologist of the Máxima Medical Centre Eindhoven and deemed suitable for implantation.
  • Neuropathic Pain as described by a score of *4 on the DN4 questionnaire

排除标准

  • Female subject of childbearing potential is pregnant/nursing or plans to become pregnant during the course of the trial.
  • Escalating or changing pain condition within the past month as evidenced by investigator examination.
  • Subject has had injection therapy or radiofrequency treatment of a target neural structure within the past 3 months
  • Subject currently has an active implantable device including ICD, pacemaker, spinal cord stimulator or intrathecal drug pump.
  • Subject is unable to operate the device.
  • Subject currently has an active infection.
  • Subject has participated in another clinical investigation within 30 days.
  • Subject has a coagulation disorder or uses anticoagulants that, in the opinion of the investigator, precludes participation.
  • Subject has a current or ongoing condition, which will probably require MRI investigation sometime in the following 2 years
  • Subject has had a spinal surgical procedure at or between vertebral levels T10-L2.
  • Subject had been diagnosed with cancer in the past 2 years, except for skin malignancies
  • Subject has a significant progressive peripheral or central neurological disorder such as Diabetic Polyneuropathy or Multiple Sclerosis

研究者

发起方
Maxima Medisch Centrum

相似试验